Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, International, Double-blind, Two-Arm, Randomized, Placebo-controlled Phase II Trial of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing ILD

NCT03099187 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT03099187
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03099187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, International, Double-blind, Two-Arm, Randomized, Placebo-controlled Phase II Trial of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing ILD
Lead sponsor
Hoffmann-La Roche
Phase
Phase 2
Overall status
Completed
Start date
May 15, 2017
Completion date
January 10, 2020
Enrollment
253 (actual)
Sites
66

Conditions

As the registry lists them; a condition with its own page is linked.

lung diseases, interstitial